Booth Preview
•
Topical Dermatological Formulation Experience - Since 1977, Dow has focused exclusively on topicals and has developed more Rx topical formulations than any other company in the world.
•
Experience With a Broad Range of Indications and Dosage Forms - Dow has developed topical formulations for psoriasis, acne, atopic dermatitis, actinic keratosis, rosacea, wrinkles, fungal infections, women’s health, topical pain, wound healing, warts and other dermatological conditions.
•
One-Stop Shop - All services needed to progress your topical formulation through development, testing, manufacturing, labeling and delivery to clinical sites are available at our facility in Petaluma, California.
•
Topical Dermatological Formulation Experience - Since 1977, Dow has focused exclusively on topicals and has developed more Rx topical formulations than any other company in the world.
•
Experience With a Broad Range of Indications and Dosage Forms - Dow has developed topical formulations for psoriasis, acne, atopic dermatitis, actinic keratosis, rosacea, wrinkles, fungal infections, women’s health, topical pain, wound healing, warts and other dermatological conditions.
•
One-Stop Shop - All services needed to progress your topical formulation through development, testing, manufacturing, labeling and delivery to clinical sites are available at our facility in Petaluma, California.
Topical Formulations Development
Topical Product Development Consulting Services
In Vitro Drug Permeation Studies
Labeling, Packaging & Distribution of Clinical Supplies
Contact Information
Dow Pharmaceutical Sciences, Inc.
• Tel: 707.793.2600
• Fax: 707.793.0145
•
Recent Videos
Related Content
Clinical Supply Planning in Europe - Balancing Cost, Flexibility and Time
December 19th 2024Article
The packaging and distribution of clinical supplies is a fundamental piece to the overall success of a clinical trial, and advance preparation can help establish a more efficient supply chain. Selecting the best geographical location for those activities, however, depends on the clinical trial protocol, business decisions, and even the investigational medicinal product (IMP) being studied.
